118 related articles for article (PubMed ID: 26785366)
1. The influence of glutamatergic receptor antagonists on biochemical and ultrastructural changes in myelin membranes of rats subjected to experimental autoimmune encephalomyelitis.
Dąbrowska-Bouta B; Strużyńska L; Chalimoniuk M; Frontczak-Baniewicz M; Sulkowski G
Folia Neuropathol; 2015; 53(4):317-26. PubMed ID: 26785366
[TBL] [Abstract][Full Text] [Related]
2. Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis.
Sulkowski G; Dąbrowska-Bouta B; Chalimoniuk M; Strużyńska L
J Neuroimmunol; 2013 Aug; 261(1-2):67-76. PubMed ID: 23746391
[TBL] [Abstract][Full Text] [Related]
3. Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.
Sulkowski G; Dąbrowska-Bouta B; Salińska E; Strużyńska L
PLoS One; 2014; 9(11):e113954. PubMed ID: 25426719
[TBL] [Abstract][Full Text] [Related]
4. Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors.
Sulkowski G; Dąbrowska-Bouta B; Strużyńska L
Biomed Res Int; 2013; 2013():186068. PubMed ID: 23936777
[TBL] [Abstract][Full Text] [Related]
5. Memantine Modulates Oxidative Stress in the Rat Brain following Experimental Autoimmune Encephalomyelitis.
Dąbrowska-Bouta B; Strużyńska L; Sidoryk-Węgrzynowicz M; Sulkowski G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768760
[TBL] [Abstract][Full Text] [Related]
6. Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine.
Paul C; Bolton C
J Pharmacol Exp Ther; 2002 Jul; 302(1):50-7. PubMed ID: 12065699
[TBL] [Abstract][Full Text] [Related]
7. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis.
Wallström E; Diener P; Ljungdahl A; Khademi M; Nilsson CG; Olsson T
J Neurol Sci; 1996 May; 137(2):89-96. PubMed ID: 8782160
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
Smith T; Groom A; Zhu B; Turski L
Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
Micu I; Jiang Q; Coderre E; Ridsdale A; Zhang L; Woulfe J; Yin X; Trapp BD; McRory JE; Rehak R; Zamponi GW; Wang W; Stys PK
Nature; 2006 Feb; 439(7079):988-92. PubMed ID: 16372019
[TBL] [Abstract][Full Text] [Related]
11. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.
Fazio F; Notartomaso S; Aronica E; Storto M; Battaglia G; Vieira E; Gatti S; Bruno V; Biagioni F; Gradini R; Nicoletti F; Di Marco R
Neuropharmacology; 2008 Sep; 55(4):491-9. PubMed ID: 18619983
[TBL] [Abstract][Full Text] [Related]
12. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
14. Demyelination and neurological signs in experimental allergic encephalomyelitis.
Pender MP
J Neuroimmunol; 1987 May; 15(1):11-24. PubMed ID: 3494747
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE).
Itoyama Y; Webster HD
J Neuroimmunol; 1982 Dec; 3(4):351-64. PubMed ID: 6184382
[TBL] [Abstract][Full Text] [Related]
16. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
18. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Bolton C; Wood EG; Ayoub SS
Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitis.
Abdurasulova IN; Serdyuk SE; Gmiro VE
Bull Exp Biol Med; 2007 Aug; 144(2):217-20. PubMed ID: 18399284
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
Yao DL; Liu X; Hudson LD; Webster HD
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
